Carebox Healthcare Solutions, the leader in clinical trial patient engagement technology, is leading the disqualification analysis conversation in Boston this September, presenting at two back-to-back industry conferences: Partnerships with Sites on September 14th and DPHARM from September 15–16th.
Presented by Caroline Melendez Daigle, VP of Services
Caroline Melendez Daigle will present a model for improving referral quality and shared sponsor-site visibility — without requiring sites to adopt new tools or route activity through a single platform.
Presented by Brian Weiss, CEO
Brian Weiss will introduce DQA (Disqualification Analysis) — a framework that maps screen failures back to their source, combining condition-based matching data, site outcomes, and patient-reported barriers to give sponsors a view across studies, therapeutic areas, campaigns, and vendors of why patients aren't progressing, and what to do about it.
"The patients who don't make it to a trial are trying to tell you something. Most recruitment programs aren't set up to listen. Learn how to turn disqualification data into something you can act on."
— Brian Weiss, CEO, Carebox
Carebox will exhibit at Booth #22 at Partnerships with Sites and at Booth #517 in the Grand Ballroom Foyer Exhibits at DPHARM.
Carebox is a clinical trial patient recruitment technology company dedicated to improving access to research-based treatment options for patients and accelerating drug development for pharmaceutical companies. By connecting patients and physicians with relevant clinical trials, Carebox addresses the primary bottleneck in clinical research recruitment, bridging the gap between complex trial landscapes and those seeking care. As the industry evolves with precision medicine, diversity goals, and AI expectations, Carebox is at the forefront of transforming how the industry informs and engages patients in clinical trials. Learn more at careboxhealth.com.